✦ LIBER ✦

Tenoten in the Therapy of Anxious Disturbances in Patients with Essential Hypertension and Coronary Heart Disease

✍ Scribed by N. P. Vanchakova; A. P. Popov

Publisher: Springer US
Year: 2009
Tongue: English
Weight: 138 KB
Volume: 148
Category: Article
ISSN: 0007-4888
DOI: 10.1007/s10517-009-0682-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Platelet Aggregation and Endothelial Fun

Platelet Aggregation and Endothelial Function in Patients with Complicated Essential Hypertension (Ischemic Stroke) and Coronary Heart Disease

✍ N. Yu. Shimohina; M. M. Petrova; A. A. Savchenko; E. G. Smertina; V. G. Ionova; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 291 KB

Cardiovascular impact of exercise and dr

Cardiovascular impact of exercise and drug therapy in older hypertensives with coronary heart disease: PREHACOR study

✍ Jean-Jacques Mourad; Nicolas Danchin; Jacques Puel; Hervé Gallois; Jérôme Msihid 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 199 KB

The clinical significance of coronary an

The clinical significance of coronary angioscopy in patients with coronary heart disease

✍ Vinzenz Hombach; Martin Höher; Hans-Wilhelm Höpp; Mathias Kochs; Thomas Eggeling 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 365 KB

Right heart catheterization in the evalu

Right heart catheterization in the evaluation of patients with suspected coronary artery disease

✍ Levin, David C. 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 3 views

Acute haemodynamic effects of ajmaline a

Acute haemodynamic effects of ajmaline and prajmaline in patients with coronary heart disease

✍ E. Sowton; I. D. Sullivan; J. C. P. Crick 📂 Article 📅 1984 🏛 Springer 🌐 English ⚖ 426 KB

Systemic and coronary hemodynamics of la

Systemic and coronary hemodynamics of labetalol in normotensive patients with ischemic heart disease

✍ Robert L. Feldman; Xavier E. Prida; Charles R. Lambert; James A. Hill 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 536 KB

The systemic and coronary hemodynamic effects of combined alpha-and beta-adrenergic blockade produced by labetalol were assessed in 24 normotensive patients with angina pectoris and an ischemic electrocardiographic response to exercise stress. Beth the intravenous (0.5 mg/kg) and oral (200 mg) formu